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Abstract One characteristic elements in the promoter of the
matrix metalloproteinase 9 (MMP-9) gene is the d(CA) repeat.
To investigate whether this element regulates the transcription of
the MMP-9 gene and its enzymatic activities, we sequenced the
promoter region isolated from esophageal carcinoma cell lines.
TE9 cells with low MMP-9 enzymatic activity had the number of
d(CA) repeats shortened from 21 to 14 or 18. TE8, TE10 and
TE11 cells with high MMP-9 activities had 21 or 23 d(CA)
repeats. Luciferase assays using MMP-9 promoter containing
18, 14 or 0 d(CA) repeats showed transcriptional activities which
were 50, 50 or 5%, respectively, of the level achieved with
promoter containing 21 d(CA) repeats. Sequence analysis of the
promoter of 223 Japanese subjects revealed that most had two
alleles with 20, 21 or 22 d(CA) repeats, whereas six had one or
two alleles with 14, 18 or 19 d(CA) repeats. We postulate that
length alteration of the d(CA) repeat causes phenotypic
differences among carcinoma cells and that microsatellite
instability may contribute to the polymorphism of d(CA) repeat
length.
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1. Introduction
Supercoiling of DNA plays an important regulatory role in
replication, recombination and transcription. Environmental
changes induce many non-B-DNA conformations which in£u-
ence these processes [1^4]. One dramatic structural transition
in DNA is that from a right-handed B-conformation to a left-
handed Z-DNA structure [5], which is thought to be involved
in gene regulation [6^12]. The most common structural tran-
sitions with the potential to form Z-structures involve sequen-
ces d(TG)n/d(CA)n, which are commonly found in many
genes [7,8,13^17]. Recently, the chromosomal instability asso-
ciated with d(CA)n repeats has received considerable interest
and this phenomenon is frequently seen in neoplastic cells
([18^20], for review [21]). However, such mutations in d(CA)
repeat length in the microsatellite DNA do not participate in
chemically induced carcinogenesis [22].
We previously reported [23,24] that phenotypic di¡erences
exist among human esophageal squamous cell carcinoma cell
lines (TE8, TE9, TE10, and TE11) based on our determina-
tions of enzymatic activity of MMP-9 (also called gelatinase B
and 92-kDa gelatinase), which is thought to play an important
role in metastasis of carcinoma cells [25,26]. Of these cell lines
examined, only the TE9 cells exhibited negligible MMP-9 en-
zymatic activity, even when stimulated by epidermal growth
factor (EGF). The TE9 cell line was originally isolated from a
poorly di¡erentiated esophageal carcinoma, and does not re-
quire MMP-9 for its malignant properties. However, the other
three cell lines, which had higher MMP-9 enzymatic activity,
were isolated from well-di¡erentiated carcinomas, and re-
quired MMP-9 for malignancy. Since the MMP-9 promoter
includes d(CA) repeats which have the potential for micro-
satellite instability [27], we sought to determine the sequence
of the promoter region of the MMP-9 gene that includes an
unstable d(CA)21 repeat. This type of analysis would reveal
whether there is any correlation between di¡erences in MMP-
9 enzymatic activities and regulation of MMP-9 gene expres-
sion by variations in d(CA) repeat length in the promoter.
In this study, we report that there are distinct di¡erences in
d(CA) repeat length in the promoter region of the MMP-9
gene isolated from TE8, TE9, TE10 and TE11 cell lines.
Moreover, the number of d(CA) repeats correlates with the
transcriptional activity of the promoter and the intrinsic
MMP-9 enzyme activity of a particular cell line. We also dis-
covered a d(CA) repeat polymorphism within the MMP-9
promoter in the Japanese population.
2. Materials and methods
2.1. Construction of reporter genes for luciferase assay
Two oligonucleotide primers selected from the sequences of the
MMP-9 promoter region (5P-AATCCAGGACTTCGTGA and 3P-
GAGGAATTTCGGGGGTGTTGT) and the genomic DNA as the
template were used for the polymerase chain reaction (PCR) to obtain
a 1868-bp DNA fragment of the MMP-9 promoter region (31879 to
312 from the transcription start site) [27,28]. The DNA fragment was
subcloned into pGEM-T Easy vector (Promega, Madison, WI, USA)
and was sequenced (ALF Express, Pharmacia Biotech, Piscataway,
NJ, USA). Mutated forms of the 1826-bp DNA fragment that con-
tained 21, 18, 14 or 0 d(CA) repeats were ampli¢ed by PCR [29] and
were cloned upstream of the luciferase gene in the pGL3 basic vector
(Promega, Madison, WI, USA) (Fig. 1).
2.2. Luciferase assay
TE9 cells (105 cells) suspended in PBS were transfected with 10 Wg
of each plasmid using electroporation (0.3 kV and 950 WF; Gene
Pulser II, Bio-Rad, Hercules, CA, USA). The transfected cells were
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cultured overnight in 12-well plates in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum (FCS),
and then exposed to EGF (PeproTech, London, UK) (50 ng/ml) for
30 h. Next the cells were lysed using a commercial luciferase assay
bu¡er (Promega, Madison, WI, USA). Aliquots of 20 Wl each of the
supernatant was reacted with 470 mM luciferin solution (Toyo Inki
Ind. Co., Tokyo, Japan). The intensity of the luminescence was meas-
ured with a luminometer (Bio-Orbit Oy, 1253 Luminometer, Turku,
Finland).
2.3. Determination of number of d(CA) repeats
To determine the length of the d(CA) repeat in the MMP-9 pro-
moter region, genomic DNA was isolated from the esophageal carci-
noma cell lines and from peripheral blood cells, and subjected to PCR
ampli¢cation. Two oligonucleotide primers (0.2 mM) 5P-TTGCCTG-
ACTTGGCAGTGGAGACTGC-3P (3210 to 3192 nt) and 5P-TGT-
TGTGGGGGCTTTAAGGAG-3P (333 to 313 nt), based on the
human MMP-9 gene sequences, were used for PCR in a reaction
mixture (25 Wl) containing 1UPCR bu¡er, 200 ng of template
DNA, dNTPs (2.5 mM) and exTaq polymerase (Takara, Tokyo, Ja-
pan). After initial denaturing at 94‡C for 5 min, PCR was performed
for 35 cycles of denaturing at 94‡C for 1 min, annealing at 60‡C for
1 min and polymerase extension at 72‡C for 1 min. The ¢nal polymer-
ase extension was for 10 min at 72‡C. The PCR products were cloned
into the pGEM-T easy vector (Promega, Madison, WI, USA) and
were sequenced using £uorescent primers and an automated DNA
sequencer (ALF Express, Pharmacia Biotech, Piscataway, NJ,
USA). In addition, PCR products were also generated using a £uo-
rescence-labeled forward primer (5P-ACTTGGCAGTGGAGACT-
GC-3P corresponding to positions 3208 to 3185 nt) and the same
3P end primer (333 to 313 nt) as mentioned above, and were either
sequenced (£uorescent PCR, [30]) or compared with DNA size
markers to determine the length of the d(CA) repeats. For the latter
method, an aliquot of each PCR product was denatured by heating
and then quickly chilled on ice and fractionated on a 14% polyacryl-
amide gel containing 7 M urea. The DNA bands were visualized by
silver staining and the length of the d(CA) repeat was estimated by
comparison with DNA size markers [31].
2.4. Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from cultured TE9 cells as previ-
ously described [32] and analyzed by EMSA as described by Tanimo-
to et al. [33]. Brie£y, a 54-bp oligonucleotide, 5P-TGCCACACACAC-
ACACACACACACACACACACACACACACACACACCCTGAC-
CC-3P (a synthetic d(CA)21 repeat (10 pmol) corresponding to
nucleotides 393 to 385) was annealed to the primer, 5P-GGGTCA-
GGGT-3P (100 pmol) and ¢lled in by Escherichia coli Klenow DNA
polymerase in the presence of dNTPs and [K-32P]dCTP to obtain the
labeled double-stranded DNA fragment. In the same way, probes for
d(CA)14, d(CA)18, d(CA)20 and d(CA)22 repeats were made. The
product size and the labeling e⁄ciencies were veri¢ed by non-denatur-
ing polyacrylamide gel electrophoresis (PAGE), and quantitated by
scintillation counting. For EMSA, DNA probes (3.2^4.0U105 cpm/Wl)
and nuclear extracts were mixed in 20 Wl of reaction bu¡er containing
50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM
DTT, 250 mM NaCl, and 0.25 mg/ml poly(dI-dC) poly(dI-dC) and
incubated for 30 min at room temperature. The DNA-protein com-
plexes were separated on a 4% polyacrylamide gel (29:1) and detected
by autoradiography.
3. Results and discussion
3.1. Sequence of the MMP-9 gene promoter in carcinoma cells
In the MMP-9 producing TE10 cells, the promoter se-
quence was exactly the same as reported previously and the
number of d(CA) repeats was 21 in both alleles (Figs. 1 and
3a) [28]. Sequence analysis of the MMP-9 promoter isolated
from TE8 and TE11 cells showed the presence of d(CA)21
and d(CA)23 repeats. In contrast, sequence analysis of the
promoter obtained from the MMP-9-low-producing TE9 cells
revealed that the d(CA) repeats were shortened to 14 or 18
(corresponding to nucleotides 390 to 3131) in one allele,
whereas the other allele contained the normal d(CA)21 repeat
length (Fig. 3a).
Since the number of d(CA) repeats determined by £uores-
cent PCR and silver staining was exactly the same as that
determined by sequencing (Fig. 3a,b), most of the experiments
described below were performed by the silver staining of £uo-
rescent PCR product to determine the number of d(CA) re-
peats.
3.2. MMP-9 promoter activity by luciferase assay
The 1868-bp DNA fragment comprising the MMP-9 pro-
moter/luciferase reporter constructs containing the d(CA) re-
peat was transfected to TE9 cells and the luciferase activities
were determined. The results showed that the promoter activ-
ities were dependent on the length of the d(CA) repeat: the
d(CA)18, d(CA)14 and d(CA)0repeats had 50%, 50% and 5%
of the activity, respectively, obtained with the d(CA)21 repeats
(Fig. 2a). This result indicated that reduction in MMP-9 gene
expression in TE9 cells correlates with shortening in the
d(CA) repeat length. Even the basal activities (in the absence
of EGF) seen in TE9 cells transfected with d(CA)18, 14 and 0
repeats were much less than that of cells transfected with the
construct containing d(CA)21 repeat. However, treatment by
EGF still increased the transcriptional activity of the MMP-9
promoter 2.5-fold, compared with the basal activity in the
absence of EGF treatment for each d(CA) repeat construct
(Fig. 2b). Taken together, these ¢ndings indicate that the
d(CA)21 repeats are required for basal activity of the
Fig. 1. Sequence of promoter region in the MMP-9 gene. Schematic
presentation of cis-acting elements and d(CA)21 repeat sequence in
the promoter region of the MMP-9 gene.
Table 1
Numbers of d(CA) repeats in 223 Japanese subjects




21 1 1 1 18 91 4
22 4 68 26 1
23 1
Subtotal 2 3 1 25 159 26 7 223
% 0.9 1.4 0.5 11.3 71.9 11.8 3.2 100
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MMP-9 promoter. These results were reproducible in other
tumor cell lines, HeLa and HT1080 cells (Fig. 2c,d), as well
as TE8 and TE11 cells (data not shown). The TE10 cell line
was not e⁄ciently transfected by electroporation and there-
fore was not tested in this study.
Our previous study using TE9 cells [24] revealed that the
MMP-9 enzymatic activity is negligible compared to the val-
ues in other cell lines, TE8, TE10 and TE11. However, tran-
scriptional activity of the MMP-9 promoter containing the
d(CA)14 repeats in TE9 cell line was only 50% less compared
to the cell line containing the d(CA)21 repeats. Even if one
allele with the d(CA)14 repeat is active, the TE-9 cells should
have much higher MMP-9 expression and enzymatic activity.
This suggests that the MMP-9 enzymatic activity in TE9 cells
is regulated not only by transcription, but also at other steps,
such as post-translational event, translation, or processing of
pro-enzyme to active enzyme.
Tae et al. [15] reported that the d(CA)28 repeats located in
the promoter region of the acetyl-CoA carboxylase gene sup-
pressed approximately 70% of the basal promoter activity.
This regulation of the promoter was dependent on the
CCAAT box element and deletion of the d(CA)28 repeat
stimulated transcription. In our study, the d(CA)21 repeat
had the opposite e¡ect; complete deletion of the d(CA)21
repeat strongly suppressed the promoter activity (to less
than 10%) of the MMP-9 promoter. Interestingly, however,
the MMP-9 promoter lacks the CCAAT box motif. Other
reports have demonstrated that d(TG)n d(CA)n-containing
Z-DNA located upstream of the rat prolactin gene, which
lacks the CCAAT box motif, inhibits promoter activity,
whereas the d(CA) repeat in the promoter region of the cyto-
solic phospholipase A2 gene does not a¡ect promoter activity
[16,34]. Therefore, the function of the d(CA) repeat seems
variable among genes. Sato and Seiki reported that the
d(CA)21 repeat does not activate transcription of the MMP-
9 gene in HT1080 cells [28] ; however, the vector constructs we
used in the luciferase assay di¡ered from theirs ; we used
1826^1868 bp long DNA fragments of the 5P £anking region
that contained variations only in the d(CA)21 repeats, where-
as they used short deletion mutants that lacked sequences that
were upstream of the d(CA)21 repeat, as in other studies as
well [15^17]. One possible explanation for the di¡erences in
the promoter activities is that the long 5P £anking sequence
deleted by Sato and Seiki contains other unknown cis-acting
elements, which may play a speci¢c DNA conformational role
involving d(CA) repeats.
Fig. 2. Promoter activity of the MMP-9 gene correlates with the length of the d(CA) repeat. a: TE9 cells were transfected with pGL3-basic vec-
tor containing the d(CA)21, d(CA)18, d(CA)13, or d(CA)0 repeat. When 1868-bp DNA including the d(CA)21 repeat was transfected into TE9
cells, maximal luciferase activity was observed, whereas when promoter/reporter plasmid of 1826^1862-bp DNA fragments containing d(CA)18,
d(CA)13 and d(CA)0 repeat was used, the luciferase activities were signi¢cantly decreased compared with that of the d(CA)21 repeat. b: E¡ect
of EGF (50 ng/ml) on luciferase activity in TE9 cells transfected with the mutant reporter plasmids. Although EGF still enhanced the promoter
activity from d(CA)14, 18 and d(CA)0 promoter constructs, the activities were much less than that observed with the d(CA)21 repeat. c and d:
HeLa and HT1080 cells transfected with the mutated luciferase vectors. The luciferase activities were calculated as percentage of the control
(the value obtained with the d(CA)21 repeat in the absence of EGF = 100%).
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3.3. Heterogeneity of the MMP-9 d(CA) repeat number in the
Japanese population
Next, we asked whether the heterogeneity of the d(CA)
repeat number observed among the carcinoma cell lines is
common in genes isolated from individuals from the Japanese
population. The number of d(CA) repeats was determined by
fractionating PCR-ampli¢ed DNA fragments on denaturing
polyacrylamide gel, followed by silver staining [31]. Some of
the samples were also analyzed by sequencing and £uorescent
PCR [30] to con¢rm the results of electrophoretic analysis.
Most of the 223 Japanese people tested had two MMP-9
alleles that contained 20 or more d(CA) repeats. However,
2.8% of the people tested had one or two alleles containing
less than 20 d(CA) repeat length (Table 1). Few people were
homozygous in shortened repeat phenotype, and varied con-
siderably among normal individuals. Therefore, the variation
in d(CA) repeat length is not unique to carcinoma cells. The
results are summarized in Table 1.
3.4. Presence of d(CA) repeat-binding protein(s) in nuclear
extracts from TE9 cells
The TE9 cell nuclear extracts contained d(CA) repeat-bind-
ing proteins that formed speci¢c complexes with all of the
d(CA) repeat probes tested (Fig. 4a). This binding was com-
pletely abolished by a 100-fold excess of either the homolo-
gous cold competitors or heterologous competitors including
di¡erent numbers of d(CA) repeats (Fig. 4b). The d(CA)21
probe showed a much higher binding a⁄nity than the
d(CA)14, d(CA)18, and d(CA)20 probes. These results are
consistent with those of the luciferase assays, indicating that
the number of d(CA) repeats correlates with the binding af-
¢nity of the nuclear protein(s) with the promoter and regula-
tion of transcriptional activity.
We found that the length of the d(CA) repeat was closely
related to the transcriptional activity of the MMP-9 promoter
and that heterogeneity of the d(CA) repeat exists in the Jap-
anese population. MMP-9 plays an important role in tumor
growth, invasion and metastasis [25,26,35^37] and is essential
for functions of many cell types, for example macrophages
[38], lymphocytes [39] and trophoblasts [40]. In addition, de-
velopment, embryogenesis, tissue remodeling and many
pathologic conditions relate to the expression of MMP-9.
We postulate that mutations of microsatellite DNA in the
promoter region of MMP-9 may exhibit pleiotropic e¡ects
among di¡erent cell types and that microsatellite instability
and/or variations exist among the general population.
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